Stepan (SCL) EVP receives stock awards as Form 4/A corrects SAR price
Filing Impact
Filing Sentiment
Form Type
4/A
Rhea-AI Filing Summary
STEPAN CO executive Robert Joseph Haire reported multiple equity awards and corrected prior pricing details. The filing shows grants on March 2, 2026 of 8,586 Stock Appreciation Rights tied to common stock at a conversion/exercise price of $50.06, 2,996 performance shares, and 5,993 restricted stock units.
He also acquired 56.765 shares of common stock at $52.51 per share, bringing direct common stock holdings to 2,538.765 shares, plus 90.269 shares held indirectly through an ESOP II Trust. This Form 4/A amends a prior report only to correct the Stock Appreciation Right exercise price from $17.47 to $50.06; all other aspects of the reported transaction remain unchanged.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Haire Robert Joseph
Role
EVP, Supply Chain
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 5,993 | $0.00 | -- |
| Grant/Award | Performance Shares | 2,996 | $0.00 | -- |
| Grant/Award | Stock Appreciation Right | 8,586 | $0.00 | -- |
| Grant/Award | Common Stock | 56.765 | $52.51 | $3K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 5,993 shares (Direct, null);
Performance Shares — 2,996 shares (Direct, null);
Stock Appreciation Right — 8,586 shares (Direct, null);
Common Stock — 2,538.765 shares (Direct, null);
Common Stock — 90.269 shares (Indirect, By ESOP II Trust)
Footnotes (1)
- Each RSU represents a contingent right to receive one share of Stepan Company common stock. Vest ratably over three years beginning on the date shown. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028. This Form 4/A amends the reporting person's original Form 4 filed on March 4, 2026 (the "Original Filing"). The Original Filing inadvertently reported an incorrect stock appreciation right ("SAR") conversion/exercise price due to an administrative error in the pricing calculation. The correct conversion/exercise price for the reported transaction is $50.06 not $17.47 as previously reported. This amendment corrects the reported conversion/exercise price. No other aspects of the reported transaction are affected.
Key Figures
Stock Appreciation Rights granted: 8,586 rights at $50.06
Performance shares granted: 2,996 shares
Restricted stock units granted: 5,993 RSUs
+4 more
7 metrics
Stock Appreciation Rights granted
8,586 rights at $50.06
Conversion/exercise price corrected for grant on March 2, 2026
Performance shares granted
2,996 shares
Vest upon certification of goals through December 31, 2028
Restricted stock units granted
5,993 RSUs
Vest ratably over three years beginning on grant date
Common stock grant
56.765 shares at $52.51
Direct common stock acquisition on February 27, 2026
Direct common stock holdings
2,538.765 shares
Total direct shares following February 27, 2026 transaction
Indirect ESOP holdings
90.269 shares
Indirect ownership via ESOP II Trust as of February 27, 2026
SAR exercise window
2027-03-02 to 2036-03-03
Exercise period for 8,586 Stock Appreciation Rights
Key Terms
Stock Appreciation Right, Performance Shares, Restricted Stock Units, ESOP II Trust, +1 more
5 terms
Stock Appreciation Right financial
"security_title: "Stock Appreciation Right" with 8,586.0000 shares at $50.0600"
A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.
Restricted Stock Units financial
"security_title: "Restricted Stock Units" with 5,993.0000 units granted"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
ESOP II Trust financial
"nature_of_ownership: "By ESOP II Trust" for 90.2690 common shares"
conversion/exercise price financial
"footnote correcting SAR conversion/exercise price to $50.06 from $17.47"
FAQ
What insider transactions did Stepan (SCL) report for Robert Joseph Haire?
Robert Joseph Haire received several equity awards, including 8,586 Stock Appreciation Rights, 2,996 performance shares, 5,993 restricted stock units, and 56.765 shares of common stock. These awards were granted as compensation, not open-market purchases or sales.
What correction does this Form 4/A make for Stepan (SCL)?
The amendment corrects the Stock Appreciation Right conversion/exercise price for Haire’s award to $50.06, previously reported as $17.47. The company states the earlier price was due to an administrative error; no other aspects of the transaction are changed.
How many Stock Appreciation Rights were granted to the Stepan (SCL) executive?
Haire was granted 8,586 Stock Appreciation Rights tied to Stepan common stock at a conversion/exercise price of $50.06. These are derivative awards that can be exercised between March 2, 2027 and March 3, 2036, according to the filing.
What performance-based awards did Stepan (SCL) grant in this filing?
The executive received 2,996 performance shares that vest only if Stepan meets specified performance goals for a period ending December 31, 2028. Vesting occurs upon certification that these performance targets have been achieved, as described in the footnotes.
What restricted stock units did Stepan (SCL) grant to the executive?
Haire received 5,993 restricted stock units, each representing a contingent right to one Stepan common share. The RSUs vest ratably over three years beginning on the grant date, aligning compensation with multi-year service and performance.
What are Robert Joseph Haire’s Stepan (SCL) common stock holdings after these transactions?
After the reported transactions, Haire directly holds 2,538.765 shares of Stepan common stock. He also has an indirect holding of 90.269 shares through an ESOP II Trust, reflecting participation in an employee stock ownership arrangement.